Creo Medical (GB:CREO) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Creo Medical’s CFO Richard Rees executed a ‘Bed and ISA’ transaction, selling and repurchasing over 174,000 company shares, while his associate Rachel Rees acquired the remaining shares. This strategic move reflects internal confidence in the medical device firm’s focus on advanced energy solutions for surgical endoscopy.
For further insights into GB:CREO stock, check out TipRanks’ Stock Analysis page.